RESUMO
The long-term results after directed thrombolytic therapy for thrombosis of infrainguinal arterial bypass reconstructions are disappointing if broad indications are applied. This work presents criteria for determining the indications for thrombolysis or the insertion of a new bypass. In a retrospective study we compared the secondary cumulative patency after bypass thrombolysis (n = 82) and after replacement bypass (n = 143). Using multivariate analysis, the influence of prognostic factors on secondary long-term patency was investigated. Our results showed that brief occlusions (< or = 3 days) in older bypasses (> or = 11 months) should be treated by thrombolysis. In all other cases, efforts should be made to replace the bypass with autologous vein. In the absence of autologous vein, we found umbilical vein to be a suitable material for vessel replacement.